Aller au contenu principal

Analyse moléculaire, modélisation et imagerie de la maladie cancéreuse

The 20 latest publications

Title Authors Publication date Source
Dynamics of circulating calprotectin accurately predict the outcome of moderate COVID-19 patients Gérôme Jules-Clément, Sarobidy Rapeteramana 06/01/22 EBioMedicine
Next-Generation Sequencing on Circulating Tumor DNA in Advanced Solid Cancer: Swiss Army Knife for the Molecular Tumor Board? A Review of the Literature Focused on FDA Approved Test Damien Vasseur, Etienne Rouleau, Ludovic Lacroix 06/01/22 Cells
The European MAPPYACTS Trial: Precision Medicine Program in Pediatric and Adolescent Patients with Recurrent Malignancies Ludovic Lacroix, Sophie Cotteret, Jean Yves Scoazec 05/01/22 Cancer Discovery
Near-Infrared Fluorescence Axillary Reverse Mapping (ARM) Procedure in Invasive Breast Cancer: Relationship between Fluorescence Signal in ARM Lymph Nodes and Clinical Outcomes Muriel Abbaci, Valérie Rouffiac, Frederic De Leeuw, Corinne Laplace-Builhé 05/01/22 Cancers
Cancer stem-like cells evade CD8<sup>+</sup>CD103<sup>+</sup> tumor-resident memory T (T<inf>RM</inf>) lymphocytes by initiating an epithelial-to-mesenchymal transition program in a human lung tumor model Aziza Caidi, Marc Deloger 04/13/22 Journal for ImmunoTherapy of Cancer
Therapeutic potential of the human endogenous retroviral envelope protein HEMO: a pan-cancer analysis Olivia Bawa, Bastien Job, Jean Yves Scoazec 04/01/22 Molecular Oncology
Single-cell DNA-seq depicts clonal evolution of multiple driver alterations in osimertinib-resistant patients Damien Vasseur, Ludovic Lacroix, Jean Yves Scoazec 04/01/22 Annals of Oncology
Gefitinib plus tremelimumab combination in refractory non-small cell lung cancer patients harbouring EGFR mutations: The GEFTREM phase I trial Marie Naigeon, Lydie Cassard, Lisa Boselli, Jonathan Grivel, Ludovic Lacroix, Nathalie Chaput 04/01/22 Lung Cancer
TGFβ receptor inhibition unleashes interferon-β production by tumor-associated macrophages and enhances radiotherapy efficacy Nicolas Signolle 03/17/22 Journal for ImmunoTherapy of Cancer
Tumor-associated high endothelial venules mediate lymphocyte entry into tumors and predict response to PD-1 plus CTLA-4 combination immunotherapy Jean Yves Scoazec 03/14/22 Cancer Cell
CD8<sup>+</sup>PD-1<sup>+</sup> to CD4<sup>+</sup>PD-1<sup>+</sup> ratio (PERLS) is associated with prognosis of patients with advanced NSCLC treated with PD-(L)1 blockers Boris Duchemann, Marie Naigeon, Lydie Cassard, Jean Mehdi Jouniaux, Lisa Boselli, Jonathan Grivel, Aude Desnoyer, Nathalie Chaput 02/07/22 Journal for ImmunoTherapy of Cancer
Diagnostic accuracy of in vivo early tumor imaging from probe-based confocal laser endomicroscopy versus histologic examination in head and neck squamous cell carcinoma Muriel Abbaci, Frederic De Leeuw, Corinne Laplace-Builhé 02/01/22 Clinical Oral Investigations
Adoptive cell therapies in thoracic malignancies Marie Naigeon, Nathalie Chaput, Boris Duchemann 01/01/22 Cancer Immunology, Immunotherapy
Clinical Utility and Outcomes Impact of Crystal Digital PCR of Sensitizing and Resistance EGFR Mutations in Patients With Advanced Non-Small Cell Lung Cancer Damien Vasseur, Cécile Jovelet, Etienne Rouleau, Ludovic Lacroix 01/01/22 Clinical Lung Cancer
A loss-of-function polymorphism in ATG16L1 compromises therapeutic outcome in head and neck carcinoma patients Virginie Marty 01/01/22 OncoImmunology
Association of AXL and PD-L1 Expression with Clinical Outcomes in Patients with Advanced Renal Cell Carcinoma Treated with PD-1 Blockade Nathalie Chaput 12/15/21 Clinical Cancer Research
Inferring the dynamics of mutated hematopoietic stem and progenitor cells induced by IFNα in myeloproliferative neoplasms Cyril Catelain, Philippe Rameau 12/02/21 Blood
Rucaparib in patients presenting a metastatic breast cancer with homologous recombination deficiency, without germline BRCA1/2 mutation Kadija Diop, Nathalie Droin 12/01/21 European Journal of Cancer
Serial transplantation unmasks galectin-9 contribution to tumor immune escape in the MB49 murine model Olivia Bawa, Nicolas Signolle, M'Boyba Diop, Philippe Dessen 12/01/21 Scientific Reports
Plasma proteomics identifies leukemia inhibitory factor (LIF) as a novel predictive biomarker of immune-checkpoint blockade resistance Nathalie Chaput 11/01/21 Annals of Oncology

Number of publications of the laboratory by scientific field (2016-2021)

Every paper can be classified in one or more scientific fields. The figure below shows the lab's number of publications in each scientific field, according to the ASJC classification (Elsevier)